Abstract:Intestinal bifidobacteria benefit human health by promoting and modulating the gut flora, and boosting therapeutic efficiency for chronic metabolic diseases and cancer. Recently, Bifidobacterium adolescentis strains with high adhesion to intestinal epithelial cells were associated with induction of T-helper 17 (Th17) cells in humans and rodents. Here, two B. adolescentis strains with similar adhesive ability but different aggregation properties were investigated for specific immunoregulatory effects, including the underlying cellular pathway, on macrophage and T-regulatory (Treg)/Th17 axis activation in vitro and in the colon of dextran sodium sulfate (DSS)-colitis mice in vivo. In-vitro, the auto-aggregative B. adolescentis strain IF1-11 induced significantly higher IL-6 and lower IL-10 secretion from immune cells, and it induced abundant Th17 cells. The non-aggregating strain IF1-03 induced significantly higher IL-10, less IL-6 and a high proportion of Treg/Th17 cells compared to total T cells. In vivo, orally administered IF1-03 protected DSS-colitis mice via activation of dendritic cells or macrophages and skewing of Treg/Th17 cells, consistent with Treg cell induction in vitro. IF1-03 exopolysaccharides showed a functional recognition pattern similar to IF1-03 for IL-10 cytokine secretion and Treg cell-differentiation induction, both dependent on the toll-like receptor 2–ERK/p38 MAPK-signaling cascade for macrophage activation. We suggest that B. adolescentis exopolysaccharide-associated enterocyte adhesion/aggregation phenotypes determine strain-specific adaptive immune responses in the gut via the macrophage-regulated Treg/Th17 axis.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the differences between two strains of *Bifidobacterium adolescentis* with similar adhesive properties but different aggregation characteristics in regulating inflammatory immune responses. Specifically, the study focuses on how these strains protect DSS - colitis mice by regulating the activation of dendritic cells or macrophages and the shift of the Treg/Th17 axis. The research aims to elucidate the underlying mechanisms of these strain - specific exopolysaccharides (EPSs), especially how they activate macrophages through the TLR2 receptor and affect the expansion, induction and function of Treg/Th17 cells through the ERK/p38 MAPK signaling cascade pathway. ### Main problems: 1. **Immunomodulatory effects**: To study the immunomodulatory effects of two *B. adolescentis* strains (IF1 - 11 and IF1 - 03) on macrophages and the Treg/Th17 axis in vitro and in vivo. 2. **Molecular mechanisms**: To explore how these strain - specific exopolysaccharides (EPSs) activate macrophages through the TLR2 receptor and affect the expansion, induction and function of Treg/Th17 cells through the ERK/p38 MAPK signaling cascade pathway. 3. **Protective effects**: To evaluate the protective effects of these strains in the DSS - colitis mouse model, especially the effects in regulating the Treg/Th17 axis. ### Research background: - **Gut microbiota**: The gut microbiota has an important impact on human health, especially in the treatment of chronic metabolic diseases and cancer. - **Treg/Th17 axis**: Treg (regulatory T cells) and Th17 (helper T cells 17) cells play a crucial role in maintaining gut immune homeostasis. - **Macrophages and DCs**: Macrophages and dendritic cells (DCs) produce cytokines and present antigens after recognizing microbial pattern molecules (PAMPs and MAMPs), thereby activating T cells and triggering adaptive immune responses. ### Research methods: - **Strain culture**: *B. adolescentis* strains isolated from the feces of breast - fed infants were cultured in MRS broth. - **Cell experiments**: RAW264.7 macrophage cell lines and splenic lymphocytes were used for in vitro experiments to evaluate the effects of strains on NO secretion and cytokine profiles. - **Animal experiments**: The DSS - induced C57BL/6 mouse colitis model was used to evaluate the protective effects of strains. ### Key findings: - **In vitro experiments**: The IF1 - 11 strain induced higher IL - 6 and lower IL - 10 secretion, while the IF1 - 03 strain induced higher IL - 10 and lower IL - 6 secretion, and the IF1 - 03 strain induced a higher proportion of Treg/Th17 cells. - **In vivo experiments**: Oral administration of the IF1 - 03 strain can protect DSS - colitis mice by activating dendritic cells or macrophages and biasing the Treg/Th17 axis. - **Molecular mechanisms**: The exopolysaccharides (EPSs) of the IF1 - 03 strain activate macrophages through the TLR2 receptor and promote IL - 10 secretion and Treg cell differentiation through the ERK/p38 MAPK signaling cascade pathway. ### Conclusion: The exopolysaccharide - related adhesion/aggregation phenotype of *B. adolescentis* strains determines their adaptive immune responses in the gut through macrophage - regulated Treg/Th17 axis. This provides a theoretical basis for further development of probiotics with specific immunomodulatory functions.

Exopolysaccharide-Producing Bifidobacterium adolescentis Strains with Similar Adhesion Property Induce Differential Regulation of Inflammatory Immune Response in Treg/Th17 Axis of DSS-Colitis Mice

<i>B. adolescentis</i> ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling

Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Commensal A4 Bacteria Inhibit Intestinal Th2-Cell Responses Through Induction Of Dendritic Cell Tgf-Beta Production

A Ropy Exopolysaccharide-Producing Strain Bifidobacterium pseudocatenulatum Bi-OTA128 Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice

Bifidobacterium breve Alleviates DSS-Induced Colitis in Mice by Maintaining the Mucosal and Epithelial Barriers and Modulating Gut Microbes

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating AHR/NRF2/NLRP3 Inflammasome Pathways through Indole-3-lactic Acid Production

Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis

Adhesive Bacteria in the Terminal Ileum of Children Correlates With Increasing Th17 Cell Activation

Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis

Potential Immunomodulatory Activity of a Selected Strain Bifidobacterium bifidum H3-R2 as Evidenced in vitro and in Immunosuppressed Mice

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota

Bifidobacteria adolescentis regulated immune responses and gut microbial composition to alleviate DNFB-induced atopic dermatitis in mice

Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner

Different Effects of Different Lactobacillus acidophilus Strains on DSS-Induced Colitis

Bifidobacterium bifidum and Bacteroides fragilis Induced Differential Immune Regulation of Enteric Glial Cells Subjected to Exogenous Inflammatory Stimulation

Exopolysaccharides from Lactobacillus plantarum YW11 improve immune response and ameliorate inflammatory bowel disease symptoms

Exopolysaccharides from Bifidobacterium longum subsp. infantis and Bifidobacterium adolescentis modulate Toll-like receptor signaling

Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice

Bifidobacterium adolescentis Isolated from Different Hosts Modifies the Intestinal Microbiota and Displays Differential Metabolic and Immunomodulatory Properties in Mice Fed a High-Fat Diet